Skip to content
WeighLab
Menu
Ranked #486 · Grade C

Signos review

Signos is a CGM-first metabolic-health company whose Signos+ plan genuinely bundles clinician-prescribed compounded semaglutide with its FDA-cleared continuous glucose monitor and coaching app.

Visit Signos Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$199/mo (starting dose, bundle, plus a separate fee, compounded)
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$2,388

Pricing verified August 2026

The Index scorecard

Signos scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month25/100
Price Transparency64/100
Nationwide Access24/100
Formulation Options53/100
Clinical Oversight84/100
Contract Flexibility20/100

Where the value is

  • Confirmed as a genuine GLP-1 prescriber, not CGM-only — the Signos+ plan bundles compounded semaglutide with the CGM, verified against the separate $127/mo CGM-only price
  • Starting price of $199/month is stated to include both the medication program and the CGM hardware/app
  • FDA-cleared CGM hardware paired with an AI-powered coaching app for ongoing glucose-guided tracking
  • Free rapid shipping and HSA/FSA eligibility
  • Unusually candid about the clinical-authority boundary: states outright that Signos itself doesn't make prescribing decisions

The tradeoffs

  • The headline $199/month is a 3- or 6-month PROGRAM rate, not a plain month-to-month subscription, and the page doesn't disclose what happens after the term ends
  • Only semaglutide is shown in the bundled program; tirzepatide availability is not confirmed anywhere accessible
  • Compounded GLP-1s are not FDA-approved finished products, despite being made in FDA-registered facilities
  • Compounding pharmacy partner and states served are not published; prescribing is handled entirely by the third-party OpenLoop Health network

The bottom line

Best for: Cost-first shoppers who want glucose-monitoring data paired with a GLP-1 prescription in one program, if a 3- or 6-month term is acceptable. Signos is a CGM-first metabolic-health company whose Signos+ plan genuinely bundles clinician-prescribed compounded semaglutide with its FDA-cleared continuous glucose monitor and coaching app.

Ranked #486 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Signos.

The 24 programs nearest this one

Pricing, states and verification reflect Signos's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Signos's site. Not medical advice; see our disclosure.

← Back to the value leaderboard